Shareholders' Equity (Deficit) (Details) - USD ($)	1 Months Ended	12 Months Ended
	Aug. 20, 2020	Dec. 31, 2020	Dec. 31, 2019	May 15, 2017	Jan. 01, 2016
Shareholders' Equity (Deficit) (Details) [Line Items]
Trusts contributed aggregate shares of common stock	76,026
Fair value of marketable securities (in Dollars)	$ 3,066,889
Aggregate shares of common stock	24,522,727
Voting right percentage		51.00%
Beneficial conversion feature (in Dollars)		$ 825,000
Debt total (in Dollars)		$ 117,857
Sales of stock, shares		76,026
Aggregate grant date fair value of warrants issued (in Dollars)			$ 54,257
Issued common shares upon exercise		927,398	4,844,184
Warrants shares exercised		1,185,715	125,000	153,625
Common shares upon exercise			93,561
Shares issued to employee		924,992	349,063
Warrant One [Member]
Shareholders' Equity (Deficit) (Details) [Line Items]
Warrants to purchase shares of common stock			250,000
Exercise price (in Dollars per share)			$ 0.50
Warrant [Member]
Shareholders' Equity (Deficit) (Details) [Line Items]
Issued warrants		3,582,873	5,864,843
Aggregate grant date fair value of warrants issued (in Dollars)		$ 231,800	$ 933,399
Deemed dividend (in Dollars)		328,179
Employee Equity Incentive Plan [Member]
Shareholders' Equity (Deficit) (Details) [Line Items]
Stock based compensation recognized for grants (in Dollars)		135,002	86,523
Unrecognized stock compensation (in Dollars)		21,293
Employee Stock Option [Member]
Shareholders' Equity (Deficit) (Details) [Line Items]
Stock based compensation recognized for grants (in Dollars)		$ 79,817	$ 127,010
Consultant [Member]
Shareholders' Equity (Deficit) (Details) [Line Items]
Issued common stock to consultant		1,114,861	560,000
Recognized expenses (in Dollars)		$ 206,483	$ 153,936
Three Separate Private Placement [Member]
Shareholders' Equity (Deficit) (Details) [Line Items]
Sales of stock, shares		7,022,867	3,239,924
Proceeds from issuable (in Dollars)		$ 698,000
Three Separate Private Placement [Member] | Warrant One [Member]
Shareholders' Equity (Deficit) (Details) [Line Items]
Warrants to purchase shares of common stock		3,511,444	1,619,962
Exercise price (in Dollars per share)		$ 0.16	$ 0.22
Three Separate Private Placement [Member] | Warrant Three [Member]
Shareholders' Equity (Deficit) (Details) [Line Items]
Exercise price (in Dollars per share)		$ 0.27	$ 0.40
Twelve Separate Private Placement [Member] | Warrant One [Member]
Shareholders' Equity (Deficit) (Details) [Line Items]
Proceeds from sale of stock (in Dollars)			$ 670,000
Series B Preferred Stock [Member]
Shareholders' Equity (Deficit) (Details) [Line Items]
Shares authorized	2,750,000	20,000,000	20,000,000
Common shares, issued		100
Common Stock [Member]
Shareholders' Equity (Deficit) (Details) [Line Items]
Sales of stock, shares			479,762
Stock subscription agreements (in Dollars)			$ 59,000
Common stock, description			The funds were received and shares were issued in January and February 2020.
Common Stock [Member] | Investment Agreement [Member]
Shareholders' Equity (Deficit) (Details) [Line Items]
Common shares, issued		5,797,348	5,074,068
Net proceeds (in Dollars)		$ 489,286	$ 929,986
Common Stock [Member] | Employee Equity Incentive Plan [Member]
Shareholders' Equity (Deficit) (Details) [Line Items]
Common shares, issued					15,503,680